DuPont Announces Research Agreement With Affinergy for BioSurfaces
DuPont has entered a research agreement with Affinergy, Inc., a Duke University spinout, to assist in the company's research and development of a new line of bio-based products for its BioSurfaces business. Financial terms were not disclosed.
DuPont selected Affinergy because of its expertise in site-specific biological delivery technology, called Interfacial Biomaterials. This technology is complementary to the peptide technology being developed by DuPont scientists for its BioSurfaces business, which seeks to combine DuPont's biotechnology and coatings know-how to create new products.